Related Experiment Video
Updated: Aug 26, 2026

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
Published on: August 19, 2021
Genetically modified filamentous phage as bactericidal agents: a pilot study
1Department of Microbiology and Genetics, Max F. Perutz Laboratories, University Departments at the Vienna Biocenter, Vienna, Austria.
Aims:
To evaluate the ability of a filamentous phage encoding lethal proteins to kill bacteria without host-cell lysis.
Methods And Results:
Bacterial survival was determined after infection of a growing Escherichia coli culture with phage M13 encoding either the restriction endonuclease BglII gene or modified phage lambda S holin genes. The genetically engineered phage exerted a high killing efficiency while leaving the cells structurally intact. When compared with a lytic phage, the release of endotoxin was minimized after infection with the genetically modified phages.
Conclusions:
Genetically engineered phage can be used for efficient killing, concomitantly minimizing endotoxin release.
Significance And Impact Of The Study:
This feasibility study provides a possible strategy for the use of genetically engineered phage as bactericidal agents by optimizing the advantages and minimizing potential risks such as release of pyrogenic cell wall components.
Insights
Genetically engineered phages efficiently kill bacteria without cell lysis, minimizing endotoxin release. This offers a safer strategy for using bacteriophage therapy against infections.
Area of Science:
- Microbiology
- Molecular Biology
- Biotechnology
Background:
- Bacteriophage therapy is a promising alternative to antibiotics.
- Conventional lytic phages cause host cell lysis, releasing endotoxins.
- Controlling endotoxin release is crucial for safe phage applications.
Purpose of the Study:
- To assess the efficacy of engineered filamentous phages in killing bacteria.
- To determine if engineered phages can prevent host-cell lysis.
- To evaluate endotoxin release compared to lytic phages.
Main Methods:
- Engineered M13 phage expressing lethal proteins (BglII or lambda S holin) were used.
- Infection of growing Escherichia coli cultures.
- Bacterial survival and endotoxin levels were quantified.
Main Results:
- Engineered phages demonstrated high bacterial killing efficiency.
- Infected bacterial cells remained structurally intact.
- Significantly reduced endotoxin release compared to lytic phage infection.
Conclusions:
- Genetically engineered phages can effectively kill bacteria without lysis.
- This approach minimizes pyrogenic cell wall component release.
- Engineered phages represent a viable strategy for safer bactericidal applications.
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Biological Methods for Microbial Control
Gene Regulation in Microbial Communities: Quorum Sensing
DNA Bacteriophages
Bacteriophages of the Human Virome

